Review on Persistent Threat of Monkeypox

Year : 2024 | Volume : | : | Page : –
By

Ali S. Shakir,

Zainab H.Al-zubaidy,

Ghofran K. Al-khafajia,

  1. Lecturer Clinical Immunology, College of Dentistry, University of Al-Qadisiyah, Diwaniyah, , Iraq
  2. Lecturer Medical Microbiology, College of Dentistry, University of Babylon, Baghdad, , Iraq
  3. Faculty of Pharmacy, Jabir Ibn Hayyan University for Medical and Pharmaceutical Sciences, Al-Najaf, , Iraq

Abstract

Monkey pox virus (at this instant notorious as MPXV, the virus that sources the lately rechristened infection Mpox) was learned at Denmark’s State Serum Organization in 1958. Closely similar to smallpox.  For the next 50 years, Mpox was primarily confined to tiny, sporadic epidemics in western and central Africa. These epidemics were primarily caused by spillover episodes, in which the virus sprang through a host animal to a human, followed by limited human-to-human transmission among intimate contacts. Outbreaks transpired external of these positions, principally as a consequence of collapsible or experience to smuggled and catching environment. In May 2022, the comprehensive layout and epidemiology of mpox improved. Some countries in Cowboy movie Europe and Arctic America, partaking no preceding involvement through Mpox diffusion, initiated reportage suitcases. Over the subsequent binary months, the sickness rapidly prolonged to virtually every mainland, using over 7,000 inveterate circumstances. What was correspondingly dreadful was that the inordinate popular of the archives broadcasts befallen concluded sexual or nearby cherished relations, primarily impacting gangs who are gay, besides/or sex thru males elderly 18-44 years ancient. Earlier epidemics were frequently instigated by spillover affairs, with trifling confirmation of fragmentary, hominid-to-social .In rejoinder, strength officialdoms nearby the creation represented swiftly. The WHO issued a Global Public Health urgent, while in United States Department Health of  Human Services labeled in 2022 Mpox epidemic as a crisis for public health. Although the outbreak appeared to peak swiftly and then decline, new cases continued to emerge. Via December 2022, tabloid occasions in the United States had alleviated at exceptionally truncated stages, but the infection consumed not been destroyed. Now, nearly two years later, some cities continue to see as many as 50 additional reported cases every month. Furthermore, wastewater surveillance data revealed irregular areas with intermittent detection.

Keywords: Health , Monkeypox virus, MPXV, Mpox

How to cite this article:
Ali S. Shakir, Zainab H.Al-zubaidy, Ghofran K. Al-khafajia. Review on Persistent Threat of Monkeypox. Research & Reviews: A Journal of Microbiology & Virology. 2024; ():-.
How to cite this URL:
Ali S. Shakir, Zainab H.Al-zubaidy, Ghofran K. Al-khafajia. Review on Persistent Threat of Monkeypox. Research & Reviews: A Journal of Microbiology & Virology. 2024; ():-. Available from: https://journals.stmjournals.com/rrjomv/article=2024/view=177412

References

  1. WHO | World Health Organization Multi-Country Monkeypox Outbreak in Non-Endemic Countries. [(accessed on 30 May 2022)].
  2. Centers for Disease Control and Prevention (CDC) 2022 Monkeypox Outbreak Global Map. [(accessed on 10 September 2022)].
  3. WHO | World Health Organization WHO Director-General’s Statement at the Press Conference Following IHR Emergency Committee Regarding the Multi-Country Outbreak of Monkeypox, 23 July 2022. [(accessed on 25 July 2022)].
  4. Sklenovská N., Van Ranst M. Emergence of Monkeypox as the Most Important Orthopoxvirus Infection in Humans. Front. Public Health. 2018;6:241.
  5. Magnus P.v., Andersen E.K., Petersen K.B., Birch-Andersen A. A pox-like disease in cynomolgus monkeys. Pathol. Microbiol. Scand. 1959;46:156–176.
  6. Arita I., Gispen R., Kalter S.S., Wah L.T., Marennikova S.S., Netter R., Tagaya I. Outbreaks of monkeypox and serological surveys in nonhuman primates. Bull. World Health Organ. 1972;46:625–631.
  7. Ladnyj I.D., Ziegler P., Kima E. A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Bull. World Health Organ. 1972;46:593–597.
  8. Rezza G. Emergence of human monkeypox in west Africa. Lancet Infect. Dis. 2019;19:797–799. doi: 10.1016/S1473-3099(19)30281-6.
  9. Bunge E.M., Hoet B., Chen L., Lienert F., Weidenthaler H., Baer L.R., Steffen R. The changing epidemiology of human monkeypox—A potential threat? A systematic review. PLoS Negl. Trop. Dis. 2022;16:e0010141.
  10. Nolen L.D., Osadebe L., Katomba J., Likofata J., Mukadi D., Monroe B., Doty J., Hughes C.M., Kabamba J., Malekani J., et al. Extended Human-to-Human Transmission during a Monkeypox Outbreak in the Democratic Republic of the Congo. Emerg. Infect. Dis. 2016;22:1014–1021.
  11. Hammarlund E., Lewis M.W., Carter S.V., Amanna I., Hansen S.G., Strelow L.I., Wong S.W., Yoshihara P., Hanifin J.M., Slifka M.K. Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox. Nat. Med. 2005;11:1005–1011.
  12. Reed K.D., Melski J.W., Graham M.B., Regnery R.L., Sotir M.J., Wegner M.V., Kazmierczak J.J., Stratman E.J., Li Y., Fairley J.A., et al. The Detection of Monkeypox in Humans in the Western Hemisphere. N. Engl. J. Med. 2004;350:342–350
  13. Beer E.M., Rao V.B. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS Negl. Trop. Dis. 2019;13:e0007791.
  14. Rimoin Anne W., Mulembakani Prime M., Johnston Sara C., Lloyd Smith James O., Kisalu Neville K., Kinkela Timothee L., Blumberg S., Thomassen Henri A., Pike Brian L., Fair Joseph N., et al. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc. Natl. Acad. Sci. USA. 2010;107:16262–16267.
  15. Petersen B.W., Kabamba J., McCollum A.M., Lushima R.S., Wemakoy E.O., Muyembe Tamfum J.-J., Nguete B., Hughes C.M., Monroe B.P., Reynolds M.G. Vaccinating against monkeypox in the Democratic Republic of the Congo. Antivir. Res. 2019;162:171–177
  16. Khodakevich L., Szczeniowski M., Nambu-ma D., Jezek Z., Marennikova S., Nakano J., Meier F. Monkeypox virus in relation to the ecological features surrounding human settlements in Bumba zone, Zaire. Trop. Geogr. Med. 1987;39:56–63.
  17. Haider N., Guitian J., Simons D., Asogun D., Ansumana R., Honeyborne I., Velavan T.P., Ntoumi F., Valdoleiros S.R., Petersen E., et al. Increased outbreaks of monkeypox highlight gaps in actual disease burden in Sub-Saharan Africa and in animal reservoirs. Int. J. Infect. Dis. 2022;122:107–111.
  18. Shaymaa Sahib Abdul-Hur Al-Jassas , Saher Mahmood  (2024). A physiological, Histological Evaluation Study of Erythropoietin Hormone Levels and some other Biomarkers in Male Albino Rats Treated with Acetaminophen Drug and Alcoholic Extract of Malus domestica Peels., Al-Harf Journal., Vol. 21., Issue. June 2024.
  19. Mathieu E., Dattani S., Ritchie H., Max R., Fiona S. Monkeypox: Cumulative Confirmed Cases, by Date of Confirmation. 2022.
  20. Falendysz E.A., Lopera J.G., Doty J.B., Nakazawa Y., Crill C., Lorenzsonn F., Kalemba L.s.N., Ronderos M.D., Mejia A., Malekani J.M., et al. Characterization of Monkeypox virus infection in African rope squirrels (Funisciurus sp.) PLoS Negl. Trop. Dis. 2017;11:e0005809.
  21. Radonić A., Metzger S., Dabrowski P.W., Couacy-Hymann E., Schuenadel L., Kurth A., Mätz-Rensing K., Boesch C., Leendertz F.H., Nitsche A. Fatal monkeypox in wild-living sooty mangabey, Côte d’Ivoire, 2012. Emerg. Infect. Dis. 2014;20:1009–1011.
  22. Guagliardo S.A.J., Monroe B., Moundjoa C., Athanase A., Okpu G., Burgado J., Townsend M.B., Satheshkumar P.S., Epperson S., Doty J.B. Asymptomatic orthopoxvirus circulation in humans in the wake of a monkeypox outbreak among chimpanzees in Cameroon. Am. J. Trop. Med. Hyg. 2020;102:206.
  23. Hanan Fadhil Kadhim , Ahmed Obeis Al-Sultany. (2024). Study of Pollen Grain from Different Taxa in The Cucurbitaceae Family., Al-Harf Journal., Vol. 22., Issue. August, 2024.
  24. De Baetselier I., Van Dijck C., Kenyon C., Coppens J., Michiels J., de Block T., Smet H., Coppens S., Vanroye F., Bugert J.J., et al. Retrospective detection of asymptomatic monkeypox virus infections among male sexual health clinic attendees in Belgium. Nat. Med. 2022.
  25. Grant R., Nguyen L.-B.L., Breban R. Modelling human-to-human transmission of monkeypox. Bull. World Health Organ. 2020;98:638.
  26. Pittman P.R., Martin J.W., Kingebeni P.M., Tamfum J.-J.M., Wan Q., Reynolds M.G., Quinn X., Norris S., Townsend M.B., Satheshkumar P.S. Clinical characterization of human monkeypox infections in the Democratic Republic of the Congo. medRxiv. 2022
  27. Hind A A., Samira K H. (2023). Isolation and identification of Proteus mirabilis bacteria from different clinical sources and investigation of some of their virulence factors., Al-Harf , Issue  August, No. 18, P: 148-160
  28. Adler H., Gould S., Hine P., Snell L.B., Wong W., Houlihan C.F., Osborne J.C., Rampling T., Beadsworth M.B., Duncan C.J., et al. Clinical features and management of human monkeypox: A retrospective observational study in the UK. Lancet. Infect. Dis. 2022;22:1153–1162.
  29. Ali S. Shakir, Alaa T. Hamza. Association of Vitamin D binding protein BP rs2282679 Gene polymorphism and Serum Levels of Vitamin D in Patients with Vitiligo., Research & Reviews : A Journal of Biotechnology.,2024; 14(2): 20–27
  30. Hobson G., Adamson J., Adler H., Firth R., Gould S., Houlihan C., Johnson C., Porter D., Rampling T., Ratcliffe L. Family cluster of three cases of monkeypox imported from Nigeria to the United Kingdom, May 2021.
  31. Nikki Rani, Mehak Khurana. Enzyme Stability Prediction using BERT and CNN-A Deep Learning Approach for Enhanced Biocatalysis. Research & Reviews : A Journal of Life Sciences. 2024; 14(02):19-35.
  32. Ali S. Shakir. Evaluation Tumor Necrosis Factor-α (TNF- α) Levels in Patients with Rheumatoid , Research & Reviews : A Journal of Immunology. 2024; 14(2): 32–38p
  33. Srishti Sharma, Sujata Mohanty. A Perspective Review on Role of Environmental Pollutants in Developing Neurodegenerative Diseases. Research & Reviews : A Journal of Life Sciences. 2024; 14(02):1-18.
  34. , Kantele A., Koopmans M., Asogun D., Yinka-Ogunleye A., Ihekweazu C., Zumla A. Human monkeypox: Epidemiologic and clinical characteristics, diagnosis, and prevention. Infect. Dis. Clin. 2019;33:1027–1043.
  35. Fenner F., Henderson D.A., Arita I., Jezek Z., Ladnyi I.D., World Health O. Smallpox and Its Eradication. World Health Organization; Geneva, Switzerland: 1988.

Ahead of Print Subscription Review Article
Volume
Received 29/09/2024
Accepted 03/10/2024
Published 08/10/2024

Check Our other Platform for Workshops in the field of AI, Biotechnology & Nanotechnology.
Check Out Platform for Webinars in the field of AI, Biotech. & Nanotech.